Immunisation experts have sought to quell safety fears over a future COVID-19 vaccine, as research shows uptake of influenza vaccines in parts of the global South is being stymied by health risk concerns.
Seth Berkley, executive director at Gavi, the Vaccine Alliance, says the vaccination community faces a “big job” to overcome misconceptions about a likely novel coronavirus inoculation.
Speaking after last week’s funding pledge summit, Gavi chair Ngozi Okonjo-Iweala said it was important for communities in the global South to know civil society was being consulted ahead of any possible coronavirus vaccination programme.
“I understand that, given the time pressures, people are somewhat concerned by the safety profile of some of these vaccines.”
Joe Cerrell, global policy and advocacy managing director, Bill and Melinda Gates Foundation
The international community pledged a record US$8.8 billion to Gavi, which helps vaccinate half of the world’s children against diseases and will coordinate a new COVID-19 vaccine financing instrument.
Joe Cerrell, global policy and advocacy managing director at the Bill and Melinda Gates Foundation, says the science community needs to build confidence by communicating how researchers produce safe vaccines.
The best thing to stop the spread of the novel coronavirus is to spread facts, Cerrell says. “I understand that, given the time pressures, people are somewhat concerned by the safety profile of some of these vaccines,” he says.
Berkley says that although scientists are working to shorten the vaccine development timeline, this would not weaken the safety tests.
Concerns were raised in April about the success of COVID-19 treatment and vaccine trials after African communities in France warned relatives in Africa to refuse to take part. Two prominent French researchers had suggested carrying out medical trials in Africa because of the high level of exposure to the virus due to a lack of personal protection and weak health systems.
A wide-ranging study that covered the Philippines, Jordan, Nicaragua and Albania found that, despite a high influenza burden in middle-income countries, paediatric vaccination coverage remained low.
Communications campaigns that highlight vaccine safety and effectiveness could be key to increasing influenza inoculation uptake, according to the study published in Vaccine last week (2 June).
Many public health campaigns focus on the severity of the disease and not on how the vaccine works, which is what matters to people, co-author Aubree Gordon, from the School of Public Health at the University of Michigan, tells SciDev.Net.
Researchers interviewed more than 3500 mothers and sought to describe their knowledge and attitudes about influenza illnesses and vaccination. They then identified the characteristics of mothers who intended to vaccinate their child.
Perceptions about safety and effectiveness were the most important predictors of a mother’s intent to vaccinate her baby, according to the study, rather than fears about the severity of the disease.
However, Lorena Tapia, a virologist and paediatrician at the University of Chile who did not participate in the study, says that when the media reports that a flu outbreak has been serious “it immediately improves the vaccination rates of the at-risk groups”.